Jeong Nam Kim-Judd, MD
NPI 1013100122ActiveIndividual· Pediatrics· Hazelwood, MO
Pediatrics (MD) in Hazelwood, Missouri, licensed in MO and IL, with an NPI issued in August 2007. Neurocrine Biosciences, Inc. was the largest of 13 companies reporting payments in 2025, $556.14 in all, mostly food and beverage.
Overview
| NPI | 1013100122 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Aug 22, 2007 |
| Last updated in NPPES | Sep 9, 2024 |
| Certified by provider | Sep 9, 2024 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Pediatrics Primary | 208000000X | 2011032430 | MO |
| Pediatrics | 208000000X | IL036128909 | IL |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|
Industry payments (Open Payments)
- 2025$556.14 · 27 payments from 13 companies
- 2024$867.61 · 43 payments from 19 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Neurocrine Biosciences, Inc. | $94.48 | 4 |
| Tolmar, Inc. | $86.11 | 3 |
| Ascendis Pharma Endocrinology Inc | $71.64 | 3 |
| Glaxosmithkline, LLC. | $62.96 | 4 |
| Azurity Pharmaceuticals, Inc. | $50.69 | 2 |
What the 2025 payments were for
- Food and Beverage$556.14 · 27 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Pediatrics providers in Hazelwood
- 1073643987
- 1902946163
- 1124177704
- 1962550319
- 1265413249
- 1558316034
- 1770559916
- 1386625408
- 1013397751